Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™
ROXYBOND, formulated with patented, first-of-its-kind abuse-deterrent technology SentryBond™, is designed to provide multiple levels of protection ...
Dogecoin, Solana Down by Double Digits as Ethereum Price Hits 15-Month Low
Leading cryptos retreated amid uncertainty around the details of President Trump's crypto reserve plans and upcoming tariffs.
Should You Buy Archer Aviation While It's Below $10?
Archer Aviation ( NYSE: ACHR ) has developed impressive electric vertical takeoff and landing ( eVTOL ) aircraft and recently raised new funding that gives it plenty of room to grow. Investor sentiment has been flying high for Archer, with the company's share price surging 65% over the last 12 ...
Evolution Petroleum Announces Acquisition of Non-Operated Oil and Natural Gas Assets in New Mexico, Texas, and Louisiana - Evolution Petroleum ( AMEX:EPM )
Adds approximately 440 net BOEPD of stable, low-decline production. Enhances cash flow visibility with a balanced commodity mix. Offers low-risk development opportunities with potential for incremental production growth. ~2.8x estimated Adjusted EBITDA1 for the next 12 months ( NTM ) 2, ...
EXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain - Mira Pharmaceuticals ( NASDAQ:MIRA )
MIRA Pharmaceuticals' Phase 1 trial for Ketamir-2 in neuropathic pain was approved in Israel, with subject recruitment set for Q1 2025. The Phase 1 study at Hadassah Medical Center includes two parts with 56 participants, evaluating safety and pharmacokinetics.
The U.S. dollar is still the world's currency - but maybe not for much longer
Concerns are rising about the sustainability of U.S. government debt and spending.
Top Wall Street Forecasters Revamp Nordstrom Price Expectations Ahead Of Q4 Earnings - Nordstrom ( NYSE:JWN )
Nordstrom, Inc. JWN will release its fourth-quarter financial results, after the closing bell, on Tuesday, March 4. Analysts expect the Seattle, Washington-based company to report quarterly earnings at 93 cents per share, down from 96 cents per share in the year-ago period.
Sabre launches strategic collaboration with trusted engineering partner Coforge to accelerate pace of product innovation and delivery - Sabre ( NASDAQ:SABR )
Fortified partnership seeks to fast-track advanced AI solutions, driving superior customer outcomes
GLOBAL X COMPLETES CHANGES FOR THREE ETFs
TORONTO, March 4, 2025 /CNW/ - Global X Investments Canada Inc. ( "Global X" or the "Manager" ) announced today that it has completed its changes ( the "Changes" ) for three exchange-traded funds, collectively, the Global X Equal Weight Canadian Pipelines Index ETF ( "PPLN" ) , Global X ...






